Jian-Hong Zhong

5PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 07, 2026
Adjuvant Immunotherapy for Hepatocellular Carcinoma: The Need for Broader Evidence.

|Feb 17, 2026
Letter: Tumour Burden Score for Predicting Extrahepatic Metastasis in Hepatocellular Carcinoma After Curative Resection.

Jia-Yong Su, Qiu-Jian Qin, Jian-Yuan Meng

|Jun 24, 2025
Tertiary lymphoid structures in HCC: Influence on immune cell profiles in tumors and on efficacy of adjuvant PD-1 inhibitor therapy after hepatectomy.

Jia-Yong Su, Jian-Rong Li, Li-Xin Pan

|Jun 16, 2025
Adjuvant Transarterial Chemoembolization After Truly Curative Resection Does Not Improve Survival of Patients With Hepatocellular Carcinoma at High Risk of Recurrence: A Target Trial Emulation Study.

Jia-Yong Su, De-Jia Huang, Shao-Ping Liu

|Apr 04, 2025
Letter: Comparison of the Efficacy of Adjuvant PD-1 Inhibitor After Curative Resection for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Related HCC Versus Other Aetiologies.

Jia-Yong Su, Kang Chen, Zhen Liu

Pageof 1

Frequent Collaborators

3 joint publications

Jian-Hong Zhong

1 joint publications

Wen-Yang Li

1 joint publications

Wen-Wen Luo